← Open Payments lookup

DANIEL ZHANG: Open Payments

NPI 1265295000 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$319 in 12 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $250 · 2025 $319

Food & beverage: $319
CompanyPaymentsAmount
ABBVIE INC.5$136
GENZYME CORPORATION2$61
Takeda Pharmaceuticals U.S.A., Inc.2$54
Phathom Pharmaceuticals, Inc.1$31
Madrigal Pharmaceuticals1$22
Novo Nordisk Inc1$16

Products named: LINZESS, DUPIXENT, VOQUEZNA, MAVYRET, EOHILIA, GATTEX, CREON, REZDIFFRA.

Industry payments across TX — which companies pay providers there.